查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541407

2024-2032 年按適應症（氣喘、慢性阻塞性肺病等）、藥物類型、給藥途徑和地區分類的支氣管擴張劑市場報告

Bronchodilators Market Report by Indication (Asthma, Chronic Obstructive Pulmonary Disease, and Others), Drug Type, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球支氣管擴張劑市場規模達376億美元。

支氣管擴張劑是用於治療長期患有氣道狹窄和發炎疾病的患者的藥物，例如氣喘、肺氣腫和慢性阻塞性肺病 (COPD)。它們透過放鬆氣道或支氣管周圍的肌肉、清除肺部黏液並使呼吸更容易來幫助緩解相關症狀。它們有片劑、液體、霧化溶液、定量吸入器和乾粉吸入器的形式。如今，支氣管擴張劑也被用來增強吸入性皮質類固醇的效果，吸入性皮質類固醇是減少發炎和預防氣喘發作的主要治療方法。

支氣管擴張劑市場趨勢：

冠狀病毒病（COVID-19）引起的急性呼吸道感染患者數量顯著增加，是影響全球支氣管擴張劑需求的關鍵因素之一。除此之外，世界各地日益嚴重的空氣污染、吸煙者數量的增加以及傳染病的日益流行都增加了肺部疾病的風險。這是市場的另一個成長誘導因素。此外，隨著年齡的成長，肺功能逐漸下降，這會使呼吸略有困難。再加上老年人口的增加和消費者支出能力的大幅提高，正在推動市場發展。其他因素，例如改善醫療基礎設施和診斷方式以及日益轉向非侵入性手術，也正在推動市場成長。此外，幾種可以幫助克服現有產品限制的新型支氣管擴張劑正處於臨床前階段。同時，許多國家的衛生機構正在支持支氣管擴張劑的研發（R&D）活動，預計將為市場創造積極的前景。

本報告回答的關鍵問題

  • 全球支氣管擴張劑市場有多大？ 2024-2032年全球支氣管擴張劑市場的預期成長率是多少？
  • 推動全球支氣管擴張劑市場的關鍵因素是什麼？
  • COVID-19 對全球支氣管擴張劑市場有何影響？
  • 根據該指標，全球支氣管擴張劑市場的細分如何？
  • 根據藥物類型，全球支氣管擴張劑市場的細分如何？
  • 根據給藥途徑，全球支氣管擴張劑市場的細分如何？
  • 全球支氣管擴張劑市場的關鍵區域有哪些？
  • 全球支氣管擴張劑市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球支氣管擴張劑市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依跡象

  • 氣喘
    • 市場趨勢
    • 市場預測
  • 慢性阻塞性肺病（COPD）
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按藥物類型

  • 擬交感神經藥
    • 市場趨勢
    • 市場預測
  • 抗膽鹼藥
    • 市場趨勢
    • 市場預測
  • 磷酸二酯酶抑制劑
    • 市場趨勢
    • 市場預測
  • 複方藥物
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依管理途徑

  • 口服
    • 市場趨勢
    • 市場預測
  • 注射
    • 市場趨勢
    • 市場預測
  • 吸入器
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • AstraZeneca plc
    • Boehringer Ingelheim International GmbH
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Novartis AG
    • Pfizer Inc.
    • Sanofi
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group plc
Product Code: SR112024A4184

The global bronchodilators market size reached US$ 37.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 55.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.4% during 2024-2032.

Bronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD). They help relieve associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier. They are available in the form of tablets, liquid, nebulizer solutions, and metered-dose and dry powder inhalers. Nowadays, bronchodilators are also utilized to enhance the effect of inhaled corticosteroids, which act as a primary treatment to reduce inflammation and prevent flare-ups in asthma.

Bronchodilators Market Trends:

A significantly rising number of patients with acute respiratory infections due to coronavirus disease (COVID-19) represents one of the key factors influencing the need for bronchodilators across the globe. Apart from this, increasing levels of air pollution, the rising number of smokers, and the growing prevalence of infectious diseases around the world are contributing to the risk of developing lung conditions. This is acting as another growth-inducing factor of the market. In addition, lung function declines gradually with age, which can make breathing slightly difficult. This, along with the increasing geriatric population and a considerable rise in consumer spending capacities, is driving the market. Other factors, such as improving healthcare infrastructure and diagnostic modalities and rising shift towards non-invasive procedures, are also propelling the market growth. Furthermore, several new classes of bronchodilators that can help overcome the limitations of existing products are in the preclinical phase stage. In confluence with this, health agencies of numerous countries are supporting research and development (R&D) activities for bronchodilators, which is anticipated to create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bronchodilators market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on indication, drug type and route of administration.

Breakup by Indication:

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Others

Breakup by Drug Type:

Sympathomimetics

Anticholinergics

Phosphodiesterase Inhibitor

Combination Drugs

Breakup by Route of Administration:

Oral

Injection

Inhaler

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

  • 1. How big is the global bronchodilators market?
  • 2. What is the expected growth rate of the global bronchodilators market during 2024-2032?
  • 3. What are the key factors driving the global bronchodilators market?
  • 4. What has been the impact of COVID-19 on the global bronchodilators market?
  • 5. What is the breakup of the global bronchodilators market based on the indication?
  • 6. What is the breakup of the global bronchodilators market based on the drug type?
  • 7. What is the breakup of the global bronchodilators market based on the route of administration?
  • 8. What are the key regions in the global bronchodilators market?
  • 9. Who are the key players/companies in the global bronchodilators market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bronchodilators Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Indication

  • 6.1 Asthma
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Sympathomimetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Anticholinergics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Phosphodiesterase Inhibitor
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Combination Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Injection
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Inhaler
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boehringer Ingelheim International GmbH
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 F. Hoffmann-La Roche Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 GlaxoSmithKline plc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Novartis AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Pfizer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Sanofi
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vectura Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bronchodilators Market: Major Drivers and Challenges
  • Figure 2: Global: Bronchodilators Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Bronchodilators Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Bronchodilators Market: Breakup by Indication (in %), 2023
  • Figure 5: Global: Bronchodilators Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Bronchodilators Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Bronchodilators Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Bronchodilators (Asthma) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Bronchodilators (Asthma) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Bronchodilators (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Bronchodilators (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Bronchodilators (Sympathomimetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Bronchodilators (Sympathomimetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Bronchodilators (Anticholinergics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Bronchodilators (Anticholinergics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Bronchodilators (Combination Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Bronchodilators (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Bronchodilators (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Bronchodilators (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Bronchodilators (Injection) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Bronchodilators (Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Bronchodilators (Inhaler) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Bronchodilators (Inhaler) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Bronchodilators Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Bronchodilators Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Bronchodilators Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Bronchodilators Industry: SWOT Analysis
  • Figure 78: Global: Bronchodilators Industry: Value Chain Analysis
  • Figure 79: Global: Bronchodilators Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bronchodilators Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bronchodilators Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 3: Global: Bronchodilators Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Bronchodilators Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Bronchodilators Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Bronchodilators Market: Competitive Structure
  • Table 7: Global: Bronchodilators Market: Key Players